|
2.7 Etiologie - Obésité
|
|
|
|
3.1 Prévention - Tabac
|
|
|
|
4. Dépistage, diagnostic et pronostic
|
|
|
|
4.12 Biopsies liquides
|
|
|
New, simple blood tests for prostate cancer [Institute of Cancer Research]
|
|
|
|
|
|
“We
are now beginning a new clinical trial, involving up to 600 men, in
which we aim to show that patients who test positive for these genetic
mutations get significantly greater benefit from chemotherapy compared
to abiraterone. If the clinical trial has positive results, we could see
the liquid biopsy adopted into more routine clinical practice in
prostate cancer.”
|
|
|
|
|
|
|
5. Traitements
|
|
|
Building the clinical evidence on metformin and cancer [Cancer World]
|
|
|
|
|
|
Population
studies, mouse models, and mechanistic studies all show that metformin,
a cheap well-tolerated diabetes drug, impacts in some way on how some
cancers develop and progress. Anna Wagstaff talks to clinicians and
researchers building the evidence on what it can deliver in the clinic.
|
|
|
|
|
|
|
5.12.1 Immunothérapies - partenariats
|
|
|
|
|
5.12.3 Immunothérapies-combinaisons
|
|
|
|
5.12.5 Immunothérapies - Pharma
|
|
|
|
|
5.12.8 Immunothérapies - Economie
|
|
|
|
|
5.2 Pharma
|
|
|
|
|
5.2.1 Pharma - Partenariats
|
|
|
|
Daiichi ditches Nektar following cancer drug flop [EndPoints]
|
|
|
|
|
|
The
duo was gambling on an early approval for Onzeald after researchers
extracted data from their BEACON study on 67 advanced breast cancer
patients with a history of brain metastases. The Committee for Medicinal
Products for Human Use was not impressed.
|
|
|
|
|
|
|
5.3.4 Traitements - AMM (FDA, EMA)
|
|
|
|
5.7 SABCS
|
|
|
|
5.8.4 ASH - CAR T
|
|
|
|
6. Lutte contre les cancers
|
|
|
|
6.1 Observation
|
|
|
Head and neck cancer survivors have long-lasting cognitive problem [Reuters]
|
|
|
|
|
|
The
findings are drawn from cognitive assessments for 80 survivors of these
tumors and a control group of 40 otherwise similar people who didn’t
have these malignancies. Two years after cancer treatment, 38 percent of
the survivors had impaired cognitive functioning, but nobody in the
control group did.
|
|
|
|
|
|
|
6.11 Patients
|
|
|
|
6.6 Publications
|
|
|
|
6.7.2 Applis
|
|
|
|